Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-22T15:29:44.392Z Has data issue: false hasContentIssue false
  • English
  • Français

Vegetable-derived isothiocyanates: anti-proliferative activity and mechanism of action

Published online by Cambridge University Press:  07 March 2007

Yuesheng Zhang ,
Song Yao  and
Jun Li
Yuesheng Zhang*
Affiliation:
Department of Chemoprevention, Roswell Park Cancer Institute, Buffalo, New York 14263, USA
Song Yao
Affiliation:
Department of Chemoprevention, Roswell Park Cancer Institute, Buffalo, New York 14263, USA
Jun Li
Affiliation:
Department of Chemoprevention, Roswell Park Cancer Institute, Buffalo, New York 14263, USA
*
*Corresponding author: Dr Y. Zhang, fax +1 716 845 1144, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Many isothiocyanates (ITC), which are available to human subjects mainly through consumption of cruciferous vegetables, demonstrate strong cancer-preventive activity in animal models. Human studies also show an inverse association between consumption of ITC and risk of cancer in several organs. Whereas earlier studies primarily focused on the ability of ITC to inhibit carcinogen-activating enzymes and induce carcinogen-detoxifying enzymes, more recent investigations have shown that ITC inhibit the proliferation of tumour cells both in vitro and in vivo by inducing apoptosis and arresting cell cycle progression. ITC cause acute cellular stress, which may be the initiating event for these effects. These findings shed new light on the mechanism of action of ITC and indicate that ITC may be useful both as cancer-preventive and therapeutic agents. ITC activate caspase 9-mediated apoptosis, apparently resulting from mitochondrial damage, and also activate caspase 8, but the mechanism remains to be defined. Cell cycle arrest caused by ITC occurs mainly in the G2/M phase, and both the G2 and M phases are targetted; critical G2-phase regulators, including cyclin B1, cell division cycle (Cdc) 2 and Cdc25C, are down regulated or inhibited, and tubulin polymerization and spindle assembly are disrupted. Moreover, ITC are metabolized in vivo through the mercapturic acid pathway, giving rise to thiol conjugates (dithiocarbamates). Studies show that these dithiocarbamates are similar to their parent ITC in exerting anti-proliferative activity. Taken together, dietary ITC are highly-promising anti-cancer agents, capable of targetting multiple cellular components that are important for tumour cell survival and proliferation.

Keywords

IsothiocyanateAnti-cancer agentCancer chemopreventive agent
Type
Symposium on ‘Phytochemicals’
Information
Proceedings of the Nutrition Society , Volume 65 , Issue 1 , February 2006 , pp. 68 - 75
Copyright
Copyright © The Nutrition Society 2006

References

Ashkenazi, A & Dixit, VM (1998) Death receptors: signaling and modulation. Science 281 1305–1308.CrossRefGoogle ScholarPubMed
Brusewitz, G, Cameron, BD, Chasseaud, LF, Gorler, K, Hawkins, DR, Koch, H & Mennicke, WH (1977) The metabolism of benzyl isothiocyanate and its cysteine conjugate. Biochemical Journal 162 99–107.CrossRefGoogle Scholar
Buttke, TM & Sandstrom, PA (1994) Oxidative stress as a mediator of apoptosis. Immunology Today 15 7–10.CrossRefGoogle ScholarPubMed
Callaway, EC, Zhang, Y, Chew, W & Chow, HHS (2004) Cellular accumulation of dietary anticarcinogenic isothiocyanates is followed by transporter-mediated export as dithiocarbamates. Cancer Letters 204 23–31.CrossRefGoogle ScholarPubMed
Chen, YR, Wang, W, Kong, AN & Tan, TH (1998) Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates. Journal of Biological Chemistry 273 1769–1775.CrossRefGoogle ScholarPubMed
Chiao, JW, Chung, FL, Kancherla, R, Ahmed, T, Mittelman, A & Conaway, CC (2002) Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. International Journal of Oncology 20 631–636.Google ScholarPubMed
Chiao, JW, Chung, FL, Krzeminski, J, Amin, S, Arshad, R, Ahmed, T & Conaway, CC (2000) Modulation of growth of human prostate cancer cells by the N-acetylcysteine conjugate of phenethyl isothiocyanate. International Journal of Oncology 16 1215–1219.Google ScholarPubMed
Chiao, JW, Wu, H, Ramaswamy, G, Conaway, CC, Chung, FL, Wang, L & Liu, D (2004) Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 25 1403–1408.CrossRefGoogle ScholarPubMed
Choi, S & Singh, SV (2005) Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. Cancer Research 65 2035–2043.CrossRefGoogle ScholarPubMed
Conaway, CC, Krzeminski, J, Amin, S & Chung, FL (2001) Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes. Chemical Research in Toxicology 14 1170–1176.CrossRefGoogle ScholarPubMed
Conaway, CC, Yang, YM & Chung, FL (2002) Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Current Drug Metabolism 3 233–255.CrossRefGoogle Scholar
Fahey, JW, Zhang, Y & Talalay, P (1997) Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proceedings of the National Academy of Sciences USA 94 10367–10372.CrossRefGoogle ScholarPubMed
Fenwick, GR, Heaney, RK & Mullin, WJ (1983) Glucosinolates and their breakdown products in food and food plants. Critical Reviews in Food Science and Nutrition 18 123–201.CrossRefGoogle ScholarPubMed
Fowke, JH, Chung, FL, Jin, F, Qi, D, Cai, Q, Conaway, C, Cheng, JR, Shu, XO, Gao, YT & Zheng, W (2003) Urinary isothiocyanate levels, Brassica, and human breast cancer. Cancer Research 63 3980–3986.Google ScholarPubMed
Gamet-Payrastre, L, Lumeau, S, Gasc, N, Cassar, G, Rollin, P & Tulliez, J (1998) Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro. Anti-Cancer Drugs 9 141–148.CrossRefGoogle ScholarPubMed
Hall, AG (1999) The role of glutathione in the regulation of apoptosis. European Journal of Clinical Investigation 29 238–245.CrossRefGoogle ScholarPubMed
Hasegawa, T, Nishino, H & Iwashima, A (1993) Isothiocyanates inhibit cell cycle progression of HeLa cells at G2/M phase. Anti-Cancer Drugs 4 273–279.CrossRefGoogle ScholarPubMed
Hecht, SS (2000) Inhibition of carcinogenesis by isothiocyanates. Drug Metabolism Reviews 32 395–411.CrossRefGoogle ScholarPubMed
Hu, R, Kim, BR, Chen, C, Hebbar, V & Kong, AN (2003) The role of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 24 1361–1367.CrossRefGoogle ScholarPubMed
Hu, K & Morris, ME (2004) Effects of benzyl-, phenethyl-, and alpha-naphthyl isothiocyanate on P-glycoprotein- and MRP1-mediated transport. Journal of Pharmaceutical Sciences 93 1901–1911.CrossRefGoogle ScholarPubMed
Huang, C, Ma, W, Li, J, Hecht, SS & Dong, Z (1998) Essential role of p53 in phenethyl isothiocyanate-induced apoptosis. Cancer Research 58 4102–4106.Google ScholarPubMed
Hudson, TS, Stoner, GD, Morse, MA, Young, H & Mallery, SR (2005) Comparison of phenethyl and 6-phenylhexyl isothiocyanate-induced toxicity in rat esophageal cell lines with and without glutathione depletion. Toxicology Letter 155 427–436.CrossRefGoogle ScholarPubMed
Insinga, A, Monestiroli, S, Ronzoni, S, Gelmetti, V, Marchesi, F, Viale, A, Altucci, L, Nervi, C, Minucci, S & Pelicci, PG (2005) Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nature Medicine 11 71–76.CrossRefGoogle ScholarPubMed
Ioannou, YM, Burka, LT & Matthews, HB (1984) Allyl isothiocyanate: comparative disposition in rats and mice. Toxicology and Applied Pharmacology 75 173–181.CrossRefGoogle ScholarPubMed
Jackson, SJ & Singletary, KW (2004 a) Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 25 219–227.CrossRefGoogle ScholarPubMed
Jackson, SJT & Singletary, KW (2004 b) Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. Journal of Nutrition 134 2229–2236.CrossRefGoogle ScholarPubMed
Ji, Y & Morris, ME (2003) Determination of phenethyl isothiocyanate in human plasma and urine by ammonia derivatization and liquid chromatography-tandem mass spectrometry. Analytical Biochemistry 323 39–47.CrossRefGoogle ScholarPubMed
Ji, Y & Morris, ME (2004) Effect of organic isothiocyanates on breast cancer resistance protein (ABCG-2)-mediated transport. Pharmaceutical Research 21 2261–2269.CrossRefGoogle Scholar
Kaum, YS, Jeong, WS & Kong, ANT (2004) Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutation Research 555 191–202.CrossRefGoogle Scholar
Kim, BR, Hu, R, Keum, YS, Hebbar, V, Shen, G, Nair, SS & Kong, ANT (2003) Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by sulforaphane. Cancer Research 64 7520–7525.Google Scholar
Lea, MA, Randolph, VM, Lee, JE, Des Bordes, C (2001) Induction of histone acetylation in mouse erythroleukemia cells by some organosulfur compounds including allyl isothiocyanate. International Journal of Cancer 92 784–789.CrossRefGoogle ScholarPubMed
Li, H, Zhu, H, Xu, CJ & Yuan, J (1998) Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94 491–501.CrossRefGoogle ScholarPubMed
Li, J, Yao, S & Zhang, Y (2005) The role of c-Jun in the AP-1 activation induced by naturally occurring isothiocyanates. Food and Chemical Toxicology 43 1373–1380.CrossRefGoogle ScholarPubMed
London, SJ, Yuan, JM, Chung, FL, Gao, YT, Coetzee, GA, Rose, RK & Yu, MC (2000) Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: A prospective study of men in Shanghai, China. Lancet 356 724–729.CrossRefGoogle Scholar
Lui, VWY, Wentzel, AL, Xiao, D, Lew, KL, Singh, SV & Grandis, JR (2003) Requirement of a carbon spacer in benzyl isothiocyanate-mediated cytotoxicity and MAPK activation in head and neck squamous cell carcinoma. Carcinogenesis 24 1705–1712.CrossRefGoogle ScholarPubMed
Miko, M & Chance, B (1975) Isothiocyanates: a new class of uncouplers. Biochimica et Biophysica Acta 396 165–174.CrossRefGoogle ScholarPubMed
Miyashita, T & Reed, JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 293–299.Google ScholarPubMed
Miyoshi, N, Uchida, K, Osawa, T & Nakamura, Y (2004) A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation. Cancer Research 64 2134–2142.CrossRefGoogle ScholarPubMed
Musk, SRR & Johnson, IT (1993) Allyl isothiocyanate is selectively toxic to transformed cells of the human colorectal tumour line HT29. Carcinogenesis 14 2079–2083.CrossRefGoogle ScholarPubMed
Myzak, MC, Karplus, PA, Chung, FL & Dashwood, RH (2004) A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Research 64 5767–5774.CrossRefGoogle ScholarPubMed
Nakamura, Y, Kawakami, M, Yoshihiro, A, Miyoshi, N, Ohigashi, H, Kawai, K, Osawa, T & Uchida, K (2002) Involvement of the mitochondrial death pathway in chemopreventive benzyl isothiocyanate-induced apoptosis. Journal of Biological Chemistry 277 8492–8499.CrossRefGoogle ScholarPubMed
Nakamura, Y, Ohigashi, H, Masuda, S, Murakami, A, Morimitsu, Y, Kawamoto, Y, Osawa, T, Imagawa, M & Uchida, K (2000) Redox regulation of glutathione S-transferase induction by benzyl isothiocyanate: correlation of enzyme induction with the formation of reactive oxygen intermediates. Cancer Research 60 219–225.Google ScholarPubMed
Nebbioso, A, Clarke, N, Voltz, E, Germain, E, Ambrosino, C, Bontempo, P et al. (2005) Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. Nature Medicine 11 77–84.CrossRefGoogle ScholarPubMed
Payen, L, Courtois, A, Loewert, M, Guillouzo, A & Fardel, Q (2001) Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane. Biochemical and Biophysical Research Communications 282 257–263.CrossRefGoogle ScholarPubMed
Pham, NA, Jacobberger, JW, Schimmer, AD, Cao, P, Gronda, M & Hedley, DW (2004) The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Molecular Cancer Therapeutics 3 1239–1248.CrossRefGoogle ScholarPubMed
Rose, P, Armstrong, JS, Chua, YL, Ong, CN & Whiteman, M (2005) β-phenylethyl isothiocyanate mediated apoptosis; contribution of Bax and the mitochondrial death pathway. International Journal of Biochemistry and Cell Biology 37 100–119.CrossRefGoogle ScholarPubMed
Rose, P, Whiteman, M, Huang, SH, Halliwell, B & Ong, CN (2003) β-phenylethyl isothiocyanate-mediated apoptosis in hepatoma HepG2 cells. Cellular and Molecular Life Sciences 60 1489–1503.CrossRefGoogle ScholarPubMed
Sasaki, S (1963) Inhibitory effects by α-naphthyl-isothiocyanate on development of hepatoma in rats treated with 3-methyl-4-dimethyl-aminoazobenzene. Journal of Nara Medical Association 14 101–115.Google Scholar
Scheid, MP, Schubert, KM & Duronio, V (1999) Regulation of Bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. Journal of Biological Chemistry 274 31108–31113.CrossRefGoogle ScholarPubMed
Seow, A, Yuan, JM, Sun, CL, van Den Berg, D, Lee, HP & Yu, MC (2002) Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis 23 2055–2061.CrossRefGoogle ScholarPubMed
Shackelford, RE, Kaufmann, WK & Paules, RS (2000) Oxidative stress and cell cycle checkpoint function. Free Radical Biology and Medicine 28 1387–1404.CrossRefGoogle ScholarPubMed
Sidransky, H, Ito, N & Verney, E (1966) Influence of alpha-naphthyl-isothiocyanate on liver tumorigenesis in rats ingesting ethionine and N-2-fluorenylacetamide. Journal of the National Cancer Institute 37 677–686.Google ScholarPubMed
Singh, AV, Xiao, D, Lew, KL, Dhir, R & Singh, SV (2004) Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 25 83–90.CrossRefGoogle ScholarPubMed
Singh, SV, Herman-Antosiewicz, A, Singh, AV, Lew, KL, Srivastava, SK, Kamath, R, Brown, KD, Zhang, L & Baskaran, R (2004) Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. Journal of Biological Chemistry 279 25813–25822.CrossRefGoogle ScholarPubMed
Singh, SV, Srivastava, SK, Choi, S, Lew, KL, Antosiewicz, J, Xiao, D et al. (2005) Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. Journal of Biological Chemistry 280 19911–19924.CrossRefGoogle ScholarPubMed
Smith, TK, Lund, EK, Parker, ML, Clarke, RG & Johnson, IT (2004) Allyl isothiocyanate causes mitotic block, loss of cell adhesion and disrupted cytoskeletal structure in HT-29 cells. Carcinogenesis 25 1409–1415.CrossRefGoogle Scholar
Spitz, MR, Duphorne, CM, Detry, MA, Pillow, PC, Amos, CI, Lei, L, de Andrade, M, Gu, X, Hong, WK & Wu, X (2000) Dietary intake of isothiocyanates: Evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiology, Biomarkers & Prevention 9 1017–1020.Google ScholarPubMed
Srivastava, SK & Singh, SV (2004) Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells. Carcinogenesis 25 1701–1709.CrossRefGoogle ScholarPubMed
Srivastava, SK, Xiao, D, Lew, KL, Hershberger, P, Kokkinakis, DM, Johnson, CS, Trump, DL & Singh, SV (2003) Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo. Carcinogenesis 24 1665–1670.CrossRefGoogle ScholarPubMed
Tang, L & Zhang, Y (2004) Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. Journal of Nutrition 134 2004–2010.CrossRefGoogle ScholarPubMed
Tang, L & Zhang, Y (2005) Mitochondria are the primary target in ITC-induced apoptosis in human bladder cancer UM-UC-3 cells. Molecular Cancer Therapeutics 4 1250–1259.CrossRefGoogle ScholarPubMed
Thornberry, NA & Lazebnik, Y (1998) Caspases: enemies within. Science 281 1312–1316.CrossRefGoogle Scholar
Xiao, D, Johnson, CS, Trump, DL & Singh, SV (2004) Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cycle arrest in PC-3 human prostate cancer cells. Molecular Cancer Therapeutics 3 567–576.CrossRefGoogle ScholarPubMed
Xiao, D & Singh, SV (2002) Phenethyl isothiocyanate-induced apoptosis in P53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Research 62 3615–3619.Google ScholarPubMed
Xiao, D, Srivastava, SK, Lew, KL, Zeng, Y, Hershberger, P, Johnson, CS, Trump, DL & Singh, SV (2003) Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carcinogenesis 24 891–897.CrossRefGoogle ScholarPubMed
Xiao, D, Zeng, Y, Choi, S, Lew, KL, Nelson, JB & Singh, SV (2005) Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetables-derived cancer chemopreventive agents, is mediated by Bak and Bax. Clinical Cancer Research 11 2670–2679.CrossRefGoogle Scholar
Xu, K & Thornalley, PJ (2000) Studies on the mechanism of the inhibition of human leukemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro. Biochemical Pharmacology 60 221–231.CrossRefGoogle ScholarPubMed
Xu, K & Thornalley, PJ (2001 a) Involvement of glutathione metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukemia cells in vitro. Biochemical Pharmacology 61 165–177.CrossRefGoogle Scholar
Xu, K & Thornalley, PJ (2001 b) Signal transduction activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK. British Journal of Cancer 84 670–673.CrossRefGoogle ScholarPubMed
Ye, L, Dinkova-Kostova, A, Wade, KL, Zhang, Y, Shapiro, TA & Talalay, P (2002) Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clinica Chimica Acta 316 43–52.CrossRefGoogle ScholarPubMed
Ye, L & Zhang, Y (2001) Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of phase 2 detoxification enzymes. Carcinogenesis 22 1987–1992.CrossRefGoogle ScholarPubMed
Zhang, Y (2000) Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis 21 1175–1182.CrossRefGoogle ScholarPubMed
Zhang, Y (2001) Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis 22 425–431.CrossRefGoogle ScholarPubMed
Zhang, Y (2004) Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutation Research 555 173–190.CrossRefGoogle ScholarPubMed
Zhang, Y & Callaway, EC (2002) High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochemical Journal 364 301–307.CrossRefGoogle ScholarPubMed
Zhang, Y, Gonzalez, V & Xu, MJ (2002) Expression and regulation of glutathione S-transferase P1–1 in cultured human epidermal cells. Journal of Dermatological Science 30 205–214.CrossRefGoogle ScholarPubMed
Zhang, Y, Li, J & Tang, L (2005) Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress. Free Radical Biology and Medicine 38 70–77.CrossRefGoogle ScholarPubMed
Zhang, Y & Talalay, P (1994) Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanism. Cancer Research 54 1976S–1981S.Google Scholar
Zhang, Y & Talalay, P (1998) Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic phase 2 enzymes. Cancer Research 58 4632–4639.Google ScholarPubMed
Zhang, Y & Tang, L (2004) Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. Journal of Nutrition 134 2004–2010.Google Scholar
Zhang, Y, Tang, L & Gonzalez, V (2003) Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Molecular Cancer Therapeutics 2 1045–1052.Google ScholarPubMed
Zhao, B, Seow, A, Lee, EJ, Poh, WT, The, M, End, P, Wang, YT, Tan, WC, Yu, MC & Lee, HP (2001) Dietary isothiocyanates, glutathione S-transferase-M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiology, Biomarkers & Prevention 10 1063–1067.Google ScholarPubMed